Careers

CO.DON finally saved – the investor took over the business operations of the Leipzig-based biopharmaceutical company with an additional location in Teltow, Brandenburg.

by

CO.DON continues to operate as a GmbH (limited liability company) LEIPZIG and TELTOW, GERMANY , Jan. 25, 2023 /PRNewswire/ — Effective January 20, 2023, CO. DONThe business activities of will continue in the legal form of GmbH (limited liability company) after transfer of reorganization. The asset transaction with Rejuvenate GmbH, a company of the US-China … Read more

Crown Bioscience will acquire Indivumed’s services business and its supporting Biobank

by

The acquisition expands the global service offering to include access and analysis of unique clinical biospecimens SAN DIEGO AND HAMBURG, Germany–( BUSINESS WIRE )– Crown Bioscience, a global contract research organization (CRO), and JSR Life Sciences, announced that they have entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH. A share … Read more

FDA Accepts OBiO Technology’s GMP Plasmid DMF

by

SHANGHAI, January 16, 2023 /PRNewswire/ — OBiO Technology (Shanghai) Corp., Ltd. (“OBiO”, 688238.SH), a contract research organization (CRO) and contract development and manufacturing organization (CDMO) focused on gene and cell therapy, recently announced that the US Food and Drug Administration (FDA) has accepted its GMP Plasmid DNA Drug Master File (DMF), DMF Number 037766. Acceptance … Read more

European Association of Cardiovascular Imaging (EACVI) Collaborates With Surgical Science to Pilot the First Online Transesophageal Echo (TOE) Testing

by

ANTIBE, France, Jan. 10, 2023 /PRNewswire/ — The EACVI and Surgical Science have joined forces to create a unique TOE online simulator, aiming to evaluate TOE knowledge and performance level among young cardiologists and assess the need for simulation training for this purpose. The study, which included over 716 cardiologists from 81 countries tested online, … Read more

39-Year-Old Making $160,000/Month Passive Income Shares His Best Advice

by

When starting a business, it can sometimes be difficult to know what to prioritize and going it alone can be overwhelming. But there are strategies you can use to avoid common pitfalls. My mission is to teach people how to make money from their passions. Here’s what I did: I went from living on food … Read more

39-Year-Old Making $160,000/Month Passive Income Shares His Best Advice

by

When starting a business, it can sometimes be difficult to know what to prioritize and going it alone can be overwhelming. But there are strategies you can use to avoid common pitfalls. My mission is to teach people how to make money from their passions. Here’s what I did: I went from living on food … Read more

Ordaōs announces the appointment of Ziwei Liang, PhD, to the role of Chief Scientific Officer

by

NEW YORK, December 15, 2022 /PRNewswire/ — Ordaōs, a biotech company designing novel mini-proteins to help drug hunters deliver life-saving treatments, today announced that it is co-founding the company Long live Liang, PhD, has been elevated to the role of Chief Scientific Officer of this emerging biotech company. In this position, Dr. Liang will lead … Read more

Casetify’s CEO shares his #1 “super underrated” business tip.

by

Wesley Ng learned the basics of running a business by watching his parents run a restaurant in Hong Kong. “Obviously not backed by risk,” the 41-year-old said with a laugh. “What’s the most important thing you have to have to survive? Profits.” Ng now runs his own business, Casetify, with the same philosophy. Based in … Read more

Biocon Biologics Completes Acquisition of Viatris’ Global Biosimilars Business

by

It closes the deal for billions of dollars, cash and stock Creates a unique, fully integrated, leading global biosimilars business with eight commercialized products Biocon Biologics will recognize the combined revenue and related earnings from the acquired joint biosimilar products immediately Viatris will provide commercial and other services for up to 2 years to ensure … Read more

Micron Biomedical secures Series A funding to commercialize MAP technology for needle-free self-administration of drugs and vaccines

by

Global Health Investment Corporation and LTS Lohmann led the Series A financing with participation from GRA Venture Fund ATLANTA, November 28, 2022 /PRNewswire/ — Micron Biomedical Inc. is a clinical-stage life sciences company developing its Micro Array Patch (MAP) technology for self-administered and simple needle-free administration of drugs and vaccines by less skilled caregivers. The … Read more